NewGenIvf Group (NIVF) Income Statement: Revenue & Earnings

NewGenIvf Group Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

NewGenIvf Group Limited income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	4.73	5.43	5.14	5.94	4.12
Cost of Revenue	3.77	3.61	3.45	4.41	3.09
Gross Profit	0.96	1.83	1.68	1.54	1.02
Operating Expenses
Research & Development	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	11.68	2.99	1.64	1.14	0.83
Operating Expenses	11.68	2.99	1.64	1.14	0.83
Operating Income	-10.73	-1.16	0.04	0.40	0.20
Other Income/Expense
Interest Income	0.00	0.01	0.00	0.00	0.00
Interest Expense	0.62	0.78	0.05	0.08	-0.09
Other Income/Expense	21.07	0.20	0.07	0.02	0.05
Income
Income Before Tax	9.73	-0.96	0.11	0.34	0.16
Income Tax Expense	0.00	-0.49	0.00	0.21	0.29
Net Income	9.88	-0.53	0.13	0.46	0.00
Net Income - Continuous Operations	9.73	-0.53	0.13	0.14	-0.14
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	10.84	0.02	0.38	0.73	0.37
EBIT	10.35	-0.18	0.15	0.42	0.20
Depreciation & Amortization	0.50	0.21	0.23	0.30	0.17
Earnings Per Share
Basic EPS	2577.00	-22.00	12.00	2714.00	-3.00
Diluted EPS	36.00	-22.00	12.00	2714.00	-3.00
Basic Shares Outstanding	0.00	0.11	0.05	0.00	0.00
Diluted Shares Outstanding	0.27	0.11	0.05	0.00	0.00